FDA Approves an Oncolytic Viral Therapy for Melanoma
Posted on02 Nov 2015
Comments0
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for IMLYGICTM (talimogene laherparepvec), a genetically... Read More